Histone deacetylase inhibitor valproic acid suppresses the growth and increases the androgen sensitivity of prostate cancer cells

We identified the molecular target by histone deacetylase (HDAC) inhibitors for exploring their potential prostate cancer (PCa) therapy. Upon HDAC inhibitors-treatment, LNCaP cell growth was suppressed, correlating with increased cellular prostatic acid phosphatase (cPAcP) expression, an authentic p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Chou, Yu-Wei, Chaturvedi, Nagendra K., Ouyang, Shougiang, Lin, Fen-Fen, Kaushik, Dharm, Wang, Jue, Kim, Isaac, Lin, Ming-Fong
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3232184/
https://ncbi.nlm.nih.gov/pubmed/21862211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2011.07.015
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados